Zymeworks Common Stock Stock Technical Analysis
| ZYME Stock | USD 23.24 0.31 1.32% |
As of the 25th of January, Zymeworks Common maintains the Downside Deviation of 3.03, market risk adjusted performance of (1.40), and Mean Deviation of 2.92. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zymeworks Common Stock, as well as the relationship between them. Please check out Zymeworks Common Stock variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Zymeworks Common Stock is priced fairly, providing market reflects its latest price of 23.24 per share. Given that Zymeworks Common Stock has jensen alpha of 0.4781, we strongly advise you to confirm Zymeworks Common Stock's prevalent market performance to make sure the company can sustain itself at a future point.
Zymeworks Common Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Zymeworks, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ZymeworksZymeworks | Build AI portfolio with Zymeworks Stock |
Zymeworks Common Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 35.62 | Strong Buy | 10 | Odds |
Most Zymeworks analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Zymeworks stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Zymeworks Common Stock, talking to its executives and customers, or listening to Zymeworks conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zymeworks Common. If investors know Zymeworks will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zymeworks Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.85) | Revenue Per Share | Quarterly Revenue Growth 0.726 | Return On Assets | Return On Equity |
The market value of Zymeworks Common Stock is measured differently than its book value, which is the value of Zymeworks that is recorded on the company's balance sheet. Investors also form their own opinion of Zymeworks Common's value that differs from its market value or its book value, called intrinsic value, which is Zymeworks Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zymeworks Common's market value can be influenced by many factors that don't directly affect Zymeworks Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zymeworks Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zymeworks Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zymeworks Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zymeworks Common 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zymeworks Common's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zymeworks Common.
| 10/27/2025 |
| 01/25/2026 |
If you would invest 0.00 in Zymeworks Common on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding Zymeworks Common Stock or generate 0.0% return on investment in Zymeworks Common over 90 days. Zymeworks Common is related to or competes with Maze Therapeutics, Ardelyx, Spyre Therapeutics, Pharvaris, Intellia Therapeutics, BioCryst Pharmaceuticals, and Immunome. Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for ... More
Zymeworks Common Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zymeworks Common's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zymeworks Common Stock upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.03 | |||
| Information Ratio | 0.0802 | |||
| Maximum Drawdown | 36.09 | |||
| Value At Risk | (4.49) | |||
| Potential Upside | 5.4 |
Zymeworks Common Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zymeworks Common's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zymeworks Common's standard deviation. In reality, there are many statistical measures that can use Zymeworks Common historical prices to predict the future Zymeworks Common's volatility.| Risk Adjusted Performance | 0.0791 | |||
| Jensen Alpha | 0.4781 | |||
| Total Risk Alpha | 0.0048 | |||
| Sortino Ratio | 0.128 | |||
| Treynor Ratio | (1.41) |
Zymeworks Common January 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0791 | |||
| Market Risk Adjusted Performance | (1.40) | |||
| Mean Deviation | 2.92 | |||
| Semi Deviation | 2.67 | |||
| Downside Deviation | 3.03 | |||
| Coefficient Of Variation | 1037.27 | |||
| Standard Deviation | 4.83 | |||
| Variance | 23.37 | |||
| Information Ratio | 0.0802 | |||
| Jensen Alpha | 0.4781 | |||
| Total Risk Alpha | 0.0048 | |||
| Sortino Ratio | 0.128 | |||
| Treynor Ratio | (1.41) | |||
| Maximum Drawdown | 36.09 | |||
| Value At Risk | (4.49) | |||
| Potential Upside | 5.4 | |||
| Downside Variance | 9.18 | |||
| Semi Variance | 7.1 | |||
| Expected Short fall | (3.52) | |||
| Skewness | 3.28 | |||
| Kurtosis | 18.33 |
Zymeworks Common Stock Backtested Returns
Zymeworks Common appears to be not too volatile, given 3 months investment horizon. Zymeworks Common Stock shows Sharpe Ratio of 0.0973, which attests that the company had a 0.0973 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Zymeworks Common Stock, which you can use to evaluate the volatility of the company. Please utilize Zymeworks Common's Mean Deviation of 2.92, downside deviation of 3.03, and Market Risk Adjusted Performance of (1.40) to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Zymeworks Common holds a performance score of 7. The firm maintains a market beta of -0.32, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Zymeworks Common are expected to decrease at a much lower rate. During the bear market, Zymeworks Common is likely to outperform the market. Please check Zymeworks Common's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Zymeworks Common's historical returns will revert.
Auto-correlation | -0.88 |
Excellent reverse predictability
Zymeworks Common Stock has excellent reverse predictability. Overlapping area represents the amount of predictability between Zymeworks Common time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zymeworks Common Stock price movement. The serial correlation of -0.88 indicates that approximately 88.0% of current Zymeworks Common price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.88 | |
| Spearman Rank Test | -0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 2.12 |
Zymeworks Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Zymeworks Common Stock Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Zymeworks Common Stock volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Zymeworks Common Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Zymeworks Common Stock on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Zymeworks Common Stock based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Zymeworks Common Stock price pattern first instead of the macroeconomic environment surrounding Zymeworks Common Stock. By analyzing Zymeworks Common's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Zymeworks Common's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Zymeworks Common specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.39 | 0.24 | 0.22 | Revenue Per Share | 1.1 | 1.01 | 0.91 |
Zymeworks Common January 25, 2026 Technical Indicators
Most technical analysis of Zymeworks help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zymeworks from various momentum indicators to cycle indicators. When you analyze Zymeworks charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0791 | |||
| Market Risk Adjusted Performance | (1.40) | |||
| Mean Deviation | 2.92 | |||
| Semi Deviation | 2.67 | |||
| Downside Deviation | 3.03 | |||
| Coefficient Of Variation | 1037.27 | |||
| Standard Deviation | 4.83 | |||
| Variance | 23.37 | |||
| Information Ratio | 0.0802 | |||
| Jensen Alpha | 0.4781 | |||
| Total Risk Alpha | 0.0048 | |||
| Sortino Ratio | 0.128 | |||
| Treynor Ratio | (1.41) | |||
| Maximum Drawdown | 36.09 | |||
| Value At Risk | (4.49) | |||
| Potential Upside | 5.4 | |||
| Downside Variance | 9.18 | |||
| Semi Variance | 7.1 | |||
| Expected Short fall | (3.52) | |||
| Skewness | 3.28 | |||
| Kurtosis | 18.33 |
Zymeworks Common January 25, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Zymeworks stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | (0.49) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 23.45 | ||
| Day Typical Price | 23.38 | ||
| Price Action Indicator | (0.36) | ||
| Market Facilitation Index | 0.63 |
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |